-
-
-
-
-
-
-
Mirum Pharmaceuticals Reports Fourth Quarter and Year-End 2025 Results and Provides Business Update
-
-
-
-
-
-
-
Mirum Pharmaceuticals, Inc. (MIRM) Tops Q2 EPS by 21c
-
-
-
-
-
-
-
Mirum Pharmaceuticals, Inc. (MIRM) Misses Q4 EPS by 155c
-
-
-
-
-
-
-
Mirum Pharmaceuticals to Announce Third Quarter 2024 Financial Results and Host Conference Call on November 12, 2024
-
-
-
-
-
-
-
Mirum Pharmaceuticals’ LIVMARLI Data Showcased at ESPGHAN Annual Meeting
-
-
-
-
-
-
-
Mirum Pharmaceuticals Presents New Data at The Liver Meeting®
-
-
-
-
-
-
-
Mirum Pharmaceuticals Announces Positive Phase 3 RESTORE Study Results Evaluating Chenodal in Patients with Cerebrotendinous Xanthomatosis
-
1,197,297 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

